Shanghai RAAS Blood Products Co., Ltd. (SHE:002252)

SHE:002252 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,096	2,983	4,001	3,978	2,747	1,953
Trading Asset Securities	-	-	197.41	237.77	219.38	262.14
Cash & Short-Term Investments	2,096	2,983	4,199	4,216	2,966	2,215
Cash Growth	-43.54%	-28.95%	-0.40%	42.11%	33.90%	27.92%
Accounts Receivable	2,904	1,810	774.08	915.44	649.52	580.2
Other Receivables	35.27	1.89	8.22	2.02	1.21	0.17
Receivables	2,939	1,812	782.3	917.46	650.73	580.37
Inventory	4,640	4,293	3,667	3,269	3,173	2,163
Prepaid Expenses	-	7.7	0.07	0.1	0.14	0.13
Other Current Assets	97.52	162.02	27.21	71.41	81.69	53.09
Total Current Assets	9,772	9,257	8,675	8,473	6,872	5,012
Property, Plant & Equipment	2,601	1,922	1,453	1,282	1,279	1,229
Long-Term Investments	15,559	16,777	16,177	15,702	13,878	13,678
Goodwill	8,308	5,073	5,073	4,703	4,900	5,261
Other Intangible Assets	738.5	485.01	233.85	175.49	163.18	172.42
Long-Term Deferred Tax Assets	95.85	75.14	89.81	83.55	104.27	96.35
Long-Term Deferred Charges	27.49	28.47	21.29	25.78	28.97	33.17
Other Long-Term Assets	918.23	12.22	205.34	13	11.54	11.71
Total Assets	38,020	33,631	31,928	30,458	27,237	25,494
Accounts Payable	1,447	1,076	1,651	1,130	956.29	87
Accrued Expenses	144.42	346.84	289.17	275.36	234.64	183.88
Short-Term Debt	447.19	-	-	-	-	7.74
Current Portion of Leases	135.9	4.61	0.41	1.98	4.09	-
Current Income Taxes Payable	68.09	25.94	94.57	91.03	53.53	7.8
Current Unearned Revenue	39.99	4.69	22.64	91.76	28.69	10.88
Other Current Liabilities	616.5	193.18	186.97	34.54	29.38	32.93
Total Current Liabilities	2,899	1,652	2,245	1,625	1,307	330.24
Long-Term Debt	2,403	-	-	-	-	-
Long-Term Leases	11.26	12.99	1.49	1.85	4.16	-
Long-Term Unearned Revenue	11.67	10.96	9.49	12.77	15.2	25.31
Long-Term Deferred Tax Liabilities	55.15	14.82	16.02	5.34	6.44	8.19
Other Long-Term Liabilities	56.52	-	7.06	-	-	-
Total Liabilities	5,437	1,691	2,279	1,645	1,332	363.73
Common Stock	6,638	6,638	6,645	6,741	6,741	6,741
Additional Paid-In Capital	14,036	14,058	13,805	14,560	14,560	14,558
Retained Earnings	12,112	10,859	9,110	7,533	5,843	4,715
Treasury Stock	-547.08	-77.18	-182.92	-	-	-
Comprehensive Income & Other	343.8	448.62	255.67	-15.72	-1,241	-891.49
Total Common Equity	32,584	31,926	29,634	28,819	25,902	25,123
Minority Interest	-	14.46	15.86	-5.37	1.72	7.28
Shareholders' Equity	32,584	31,941	29,650	28,813	25,904	25,130
Total Liabilities & Equity	38,020	33,631	31,928	30,458	27,237	25,494
Total Debt	2,997	17.59	1.91	3.82	8.25	7.74
Net Cash (Debt)	-901.21	2,965	4,197	4,212	2,958	2,208
Net Cash Growth	-	-29.34%	-0.36%	42.38%	34.00%	27.48%
Net Cash Per Share	-0.14	0.45	0.64	0.62	0.44	0.34
Filing Date Shares Outstanding	6,586	6,617	6,605	6,741	6,741	6,741
Total Common Shares Outstanding	6,586	6,617	6,605	6,741	6,741	6,741
Working Capital	6,873	7,606	6,431	6,849	5,566	4,682
Book Value Per Share	4.95	4.83	4.49	4.28	3.84	3.73
Tangible Book Value	23,537	26,368	24,327	23,940	20,839	19,689
Tangible Book Value Per Share	3.57	3.99	3.68	3.55	3.09	2.92
Buildings	-	1,661	1,343	1,195	1,146	1,016
Machinery	-	1,287	1,216	1,132	1,074	988.43
Construction In Progress	-	289.21	134.03	74.19	26.89	105.48

Source: S&P Global Market Intelligence. Standard template. Financial Sources.